VCM
NUVB icon

Versant Capital Management’s Nuvation Bio NUVB Stock Holding History

Versant Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$886 Hold
156
– – ﹤0.01% 2654
2026
Q1 		$669 Buy
+156
New +$869 ﹤0.01% 2697

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Versant Capital Management's NUVB Position: Q2 2026 in Review

Versant Capital Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 156 shares worth $886. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

Versant Capital Management first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Versant Capital Management held 156 shares of Nuvation Bio worth $886 as of Q2 2026.
  • Versant Capital Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2654 holding.
  • Versant Capital Management first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.